Related Experiment Video
Updated: Nov 29, 2025

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
The Global Alliance for iPSC Therapies (GAiT)
Stephen Sullivan1, Patrick Ginty2, Siofradh McMahon3
1Global Alliance for iPSC Therapies (GAiT), Jack Copland Centre, Heriot-Watt Research Park, Edinburgh, UK.
Abstract:
The Global Alliance for iPSC Therapies (GAiT) is a new initiative to support the implementation and clinical application of therapies derived from pluripotent stem cells to the benefit of patients globally. GAiT's mission is to serve as a central, international resource for those organisations developing therapies from clinical-grade induced pluripotent stem cells, and to support the expansion of this nascent field. With the support of its international partners, GAiT already has an early position on manufacturing, regulatory and quality standards. This article details GAiT's development, its mission and structure, as well as how, and by whom, it is funded. The article ends with brief overview of current and upcoming activities.

